Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046798922> ?p ?o ?g. }
- W2046798922 endingPage "465" @default.
- W2046798922 startingPage "457" @default.
- W2046798922 abstract "Medal Review5 February 2009free access Making a grade: Sonic Hedgehog signalling and the control of neural cell fate James Briscoe Corresponding Author James Briscoe Developmental Neurobiology, National Institute for Medical Research, London, UK Search for more papers by this author James Briscoe Corresponding Author James Briscoe Developmental Neurobiology, National Institute for Medical Research, London, UK Search for more papers by this author Author Information James Briscoe 1 1Developmental Neurobiology, National Institute for Medical Research, London, UK *Corresponding author. Developmental Neurobiology, National Institute for Medical Research (NIMR), MRC, The Ridgeway, Mill Hill, London NW7 1AA, UK. Tel.: +44 20 8816 2559; Fax: +44 20 8816 2523; E-mail: [email protected] The EMBO Journal (2009)28:457-465https://doi.org/10.1038/emboj.2009.12 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info My grandfather once told me that you should never do anything that might win you a medal. This advice came from his time in the military and although he was a man whose opinion I respected greatly, this was one piece of advice that I never thought would be relevant to me as a scientist. In my defence, it was never my intention or ambition to win a medal: no one could have been more surprised and delighted than I was when I received the email from EMBO informing me that I had won the Gold Medal. Indeed, looking back, I can honestly say it was never my intention or ambition to become a research scientist. Although one or two of my current colleagues appear to have had well-structured career plans before they could walk, read or say ‘tenure committee decision’ I did not. Similar to many scientists I suspect, I accidentally fell into research. I enjoyed and did reasonably well in science classes at school, so it was obvious to choose a science subject when thinking about university. I ended up at Warwick University studying Microbiology and Virology, a course that involved a great deal of molecular biology. The elegance and complexity of bacterial and viral life and the way in which studying these organisms at a molecular level seemed to resolve the complexity to simple, straightforward explanations of function captivated me. An intercalated year spent working at Amersham International in Cardiff (now GE Healthcare) reinforced this view and whetted my appetite for some proper research. Back at Warwick for my final year, I was particularly struck by how much had been learned about the mechanism at work in eukaryotic cells from the study of viruses and viral infections. Signalling, the start With this in mind, I decided to look for a suitable PhD position. Certainly my university studies and experience at Amersham contributed to this decision, but it is also important to note that this was 1992, the depth of the recession in the UK. Seeing my friends lose their jobs and struggle to make ends meet was also a strong motivator. A safe academic job seemed preferable to the uncertainties of life in the ‘real world’. I was fortunate to gain a place in Ian Kerr's lab at the Lincolns Inn Fields laboratories of the Imperial Cancer Research Fund (now Cancer Research UK). I was doubly fortunate to arrive in the lab and institute at just the right time. Ian had a long-standing interest in unravelling how interferon (IFN) initiated an antiviral state in cells. Together with George Stark's group, which had occupied an adjoining space in the institute, they had embarked on a somatic cell genetic approach to identify genes required for the IFN response (Stark, 1997). This was beginning to come to fruition as I joined the lab. Between them, the labs had screened for and isolated several mutant cell lines that were unresponsive to IFNα/β and/or IFNγ. By identifying the mutated gene in one of these lines, Sandra Pellegrini had already shown that the tyrosine kinase Tyk2 was a component of the IFN signal-transduction pathway (Pellegrini et al, 1989; Velazquez et al, 1992). When I joined the lab, I was set to work with an experienced postdoc, Mathias Müller, to help find the defective genes in two further mutants. One of the cell lines turned out to be deficient in a STAT transcription factor that forms part of the IFN-regulated transcriptional complex (Müller et al, 1993a). For the other cell line, I was given the job of testing a series of candidate genes. On the basis of our hunches, one candidate was the Tyk2-related kinase JAK1. Meanwhile, Mathias was busy with more complicated experiments using cDNA libraries to screen for clones that restored IFN responses in the mutant cells, in case none of our guesses paid off. My task was simple. It involved transfecting mutant cells with candidate genes, exposing them to IFN, preparing RNA and then using RNase protection assays to test whether the induction of IFN-dependent gene expression had been re-established. The assay was usually finished late on the fifth day of the experiment and ordinarily the assays would be exposed to autoradiographic film overnight, ready to be analysed the next morning. But we were always impatient. So instead of overnight, we would set up the exposure and then nip around the corner to the George pub for an hour. After a pint or two, Mathias and I would return and run the film through the developer. After such a short exposure, the bands on the film were very faint, but if you held it up to the light at just the right angle you could make them out. I remember doing this with the assay containing Jak1 and hardly believing my eyes when I saw weak bands indicating that the mutants had indeed regained an IFN response (Müller et al, 1993b). The excitement and exhilaration of this experience hooked me into research. These rare moments when you see a result that nobody else has seen before, when for a short period you are the only person to have this knowledge, still make science rewarding and compelling. These studies, together with elegant biochemical and molecular experiments from the labs of Darnell, Ihle and co-workers in the USA, were the foundation of what is now referred to as the JAK/STAT signalling pathway (Darnell et al, 1994; Ihle, 1995). It was an exciting time. Hardly a week seemed to pass without the JAKs and STATs being implicated in another signal-transduction pathway and the mutant cell lines proved an invaluable resource. We were able to use them to show that the cytokine IL-6 used the JAK/STAT pathway. They were the ideal tools for molecular structural studies of the JAK and STAT proteins and for dissecting the mechanism of signal transduction (Guschin et al, 1995; Briscoe et al, 1996; Kohlhuber et al, 1997). Ian was a challenging but purposeful supervisor, always focused and supportive and I could not have asked for more generous and helpful colleagues in the lab. Moreover, the entire atmosphere at ICRF was vibrant and stimulating. To me it seemed like the centre of the signal-transduction world; down the corridor Richard Treisman's lab was dissecting the MAP kinase pathway, whereas a floor below Julian Downward's lab was identifying new Ras effectors and Peter Parker's lab was analysing PKC signalling. This atmosphere was further enhanced when Paul Nurse and a group of developmental biologists, including Phil Ingham, David Ish-Horowitz and Julian Lewis, moved to the institute. The seminars from these groups were my first exposure to embryology, introducing me to the type of questions that developmental biologists would like to tackle. The images of embryos were more aesthetically pleasing than the graphs and blots I was accustomed to and the questions the researchers asked seemed to me to be more profound. I began to realize that this was a subject I wanted to pursue. Specifically, having spent the previous few years studying the mechanisms of signal transduction in tissue culture cells, I decided I wanted to analyse a signal-transduction mechanism in vivo during embryogenesis. Moving into morphogens Once again, having made a decision, I found myself in a fortunate situation when Tom Jessell offered me a postdoc position in his lab at Columbia Medical School in New York City. Tom is interested in understanding the molecular mechanisms that direct the assembly of neuronal circuits in the spinal cord and how the organization of these circuits coordinates muscle movement and behaviour (Jessell, 2000). A first step in this process is the production of the appropriate neuronal subtypes in the right place and time in the forming neural tube. The question of how different types of neurons are produced in their correct positions in the spinal cord is a specific example of a general and fundamental problem in developmental biology. How do cells know where they are within a tissue and how is this information translated so that they form the appropriate structures for their positions? The framework that has emerged over the last century to answer this question involves the concept of positional information and signalling gradients. Lewis Wolpert best encapsulated this idea in a highly influential paper in 1969 (Wolpert 1969, 1996) in which he introduced what is now called the French Flag Model. This is a general mechanism to divide a field of cells into three equal partitions such as the red, white and blue of the French tricolour. In the model, a fixed part of the tissue is postulated to correspond to an organizer that produces a signal. The signal propagates through the rest of the tissue to establish a gradient. Cells within the tissue respond and interpret the graded signal in a quantitative manner. Cells therefore ascertain their distance from the organizer according to the concentration of the signal (Figure 1A). The beauty of this model is that the abstract concept of positional information is replaced by a tangible biochemical coordinate system that defines the location of a cell with respect to a fixed point within the tissue. The term morphogen was adopted to define signals that function in this way. This definition emphasizes two characteristics of a morphogen: it must function in a concentration-dependent manner to induce different responses at different thresholds and it must spread through a tissue to act at a distance from its source. The model also raises several additional questions that have to be answered for a complete understanding of how a morphogen works. How does the signal spread through the tissue to establish a gradient? How is the extracellular gradient perceived by responding cells, specifically how is the quantitative information transduced across the membrane and through the signalling pathway to control differential gene expression? How is the continuous graded information interpreted to generate discrete, all-or-none changes in gene expression that must underpin the switches in cell type produced at different concentrations of signal? Figure 1.Sonic Hedgehog acts in a graded manner to pattern the ventral neural tube. (A) A morphogen can pattern a developing tissue. A secreted signal (blue) is produced from a localized source (S) and spreads through the tissue to establish a gradient. Cells respond to different concentrations of the signal by regulating different sets of genes (red, orange and yellow). This induces distinct cell fates (A, B and C) at different distances from S (adapted from the French Flag Model in Wolpert, 1969). (B) Shh protein (brown) is produced from the notochord (n) and floor plate at the ventral midline of the neural tube. Shh spreads dorsally establishing a gradient that controls the generation of distinct neuronal subtypes (interneurons (V0–V3) and motor neurons (MN)). In vitro, different concentrations of Shh are sufficient to induce the distinct neuronal subtypes. The concentration of Shh necessary to induce a specific subtype corresponds to its position of generation in vivo. Download figure Download PowerPoint These issues are of particular relevance in the spinal cord where several distinct classes of neurons including motor neurons (MNs) and a number of interneurons involved in relaying sensory information and coordinating motor output are generated (Jessell, 2000). Each neuronal population arises from blocks of proliferating progenitors that are arrayed in a stereotypic order along the dorsal–ventral (DV) axis of the neural tube. Experiments that dated back to the 1920s indicated that in the ventral half of the spinal cord the pattern of neuronal generation is directed by cues emanating from the floor plate, a population of cells that reside at the ventral midline of the neural tube, and the notochord (reviewed in Placzek et al, 1991). A couple of years before I arrived in New York, the Jessell lab and several other labs cloned vertebrate homologues of the Drosophila gene Hedgehog, which encode secreted signalling proteins (Echelard et al, 1993; Krauss et al, 1993; Riddle et al, 1993; Chang et al, 1994; Roelink et al, 1994). It turned out that one of them, Sonic Hedgehog (Shh), was expressed in the notochord and floor plate and corresponds to the instructive cue that provides DV polarity to the ventral neural tube (Figure 1B). Moreover, the initial studies strongly hinted that Shh patterned the neural tube in a concentration-dependent manner, as predicted if it was a morphogen (Marti et al, 1995; Roelink et al, 1995). Whether Shh satisfied the exacting criteria necessary to qualify it as a morphogen and how cells interpreted the signal to specify distinct neuronal cell types remained to be determined. These were the questions that excited me on arriving in the Jessell lab. However, having no previous experience in developmental biology and never having laid hands on an embryo before, I teamed up with a skilled developmental biologist, Johan Ericson. We worked closely together. Johan showed extreme patience during the first few months as I tried to learn the experimental techniques that were much more delicate than ones I used previously. He also showed a similar level of patience, but for a much longer period of time, on the Bronx public golf course where in response to his drives straight up the middle of the fairway, I would inevitably hack my way through the rough, zigzagging slowly towards the green. My golf never improved, but nonetheless, the scientific partnership with Johan continued with long discussions about which experiments to do and arguments over what the results meant. These were interspersed by sage and timely advice from Tom offering piercing insight and ensuring we kept our focus. The idea that Shh was necessary for correct formation of MNs and other ventral neuronal subtypes in vivo was supported by loss-of-function studies (Chiang et al, 1996; Ericson et al, 1996). To further understand how Shh controlled neuronal subtype identity, we carried out experiments using explants of naïve neural tissue. The results indicated that exposure to varying concentrations of Shh protein induced distinct neuronal subtypes characteristic of the ventral neural tube (Ericson et al, 1997a, 1997b). Progressive 2- to 3-fold changes in Shh concentration led to the generation of the different neuronal subtypes and there was a good correlation between the concentration of Shh necessary to induce each neuronal subtype and their position of generation in vivo (Figure 1B). Thus, the induction of neurons generated in more ventral regions of the neural tube required correspondingly higher Shh concentrations. In addition to being necessary for their development then, Shh was sufficient to induce ventral interneurons and MNs in neural tissue. Furthermore, these experiments supported the idea that Shh functions as a morphogen with cells in the ventral neural tube being exposed to ventralHIGH–dorsalLOW gradient of Shh, emanating from the ventrally located notochord and floor plate. Coding neural cell fate These findings highlighted the question of how positional identity is imposed on progenitor cells and how this determines neuronal subtype identity. A series of studies over the next few years suggested that a group of transcription factors, predominately homeodomain proteins, were important intermediaries in the process (Ericson et al, 1997a, 1997b; Briscoe et al, 1999, 2000; Sander et al, 2000; Novitch et al, 2001; Vallstedt et al, 2001). These transcription factors exhibit distinct patterns of expression along the DV axis of the neural tube (Figure 2). On the basis of their mode of regulation by Shh signalling, we subdivided them into two groups, termed class I and II proteins. The threshold responses of the proteins to graded Shh signalling were defined using cultures of chick explants. This provided evidence that the expression of each class I protein is repressed at distinct thresholds of Shh activity. Consequently, their ventral limits of expression are determined by Shh signalling. Conversely, neural expression of the class II proteins depends on Shh signalling, so their dorsal boundaries of expression are defined by graded Shh signaling. The combined expression profiles of both classes of proteins defined five domains of progenitors within the ventral neural tube, each of which generated a distinct neuronal subtype. Thus, the profile of homeodomain protein expression appeared to correspond to a transcriptional code that assigns positional identity to progenitors that prefigured the neuronal subtype generated by each domain. Figure 2.Graded Shh signalling acts by controlling the expression of a set of transcription factors in neural progenitors. (A) Shh signalling results in the repression of class I proteins such as Pax6 and Dbx2 and is required for the activation of class II proteins such as Nkx2.2 and Nkx6.1. Selective cross-repressive interactions between pairs of class I and II proteins generate discrete switches in gene expression. The combinatorial expression of class I and II proteins defines five domains of progenitors in the ventral neural tube. These progenitor domains are arrayed along the dorsal–ventral axis and each domain generates one of the distinct neuronal subtypes characteristic of the ventral neural tube. (B) The expression profile of the transcription factors Pax7, Pax6, Olig2 and Nkx6.1 represent examples of the spatially restricted expression patterns that delineate distinct progenitor domains in the neural tube. Download figure Download PowerPoint The idea that the progenitor transcription factor code determined the fate of differentiating postmitotic neurons was supported by gain- and loss-of-function experiments in chick and mouse embryos (Ericson et al, 1997a, 1997b; Briscoe et al, 1999, 2000; Sander et al, 2000; Vallstedt et al, 2001). Forced expression of a class I or II protein in the neural tube changed the position in which individual neuronal subtypes were generated in a manner predicted by the normal expression profile of the class I and II proteins. Conversely, the targeted inactivation in mice of individual progenitor transcription factors resulted in predictable switches of neuronal fate. In these experiments, we were enabled by a generous supply of mutant embryos from several labs, in particular Lori Sussel and John Rubenstein in San Francisco and Pen Rashbass and Veronica Van Heyningen in Edinburgh. These experiments also revealed the presence of selective cross-repressive interactions between pairs of class I and II proteins expressed in adjacent progenitor domains (Figure 2A). This first became apparent for the class II protein Nkx2.2 and the class I protein Pax6 (Ericson et al, 1997a, 1997b; Briscoe et al, 2000). The observation that Nkx2.2 expanded dorsally in embryos lacking Pax6, resulted in another of those infrequent but exciting scientific moments. It suggested how the system could be operating, further underscored when gain-of-function experiments indicated a mutual cross-repression between Pax6 and Nkx2.2. Subsequently similar observations were extended to other pairs of class I and II proteins (Briscoe et al, 2000; Vallstedt et al, 2001). Taken together, the data indicated that cross-repression between pairs of class I and II proteins established the DV boundaries of gene expression, thereby defining the positions at which distinct neuronal subtypes are generated. The cross-repressive interactions also provided a plausible explanation for the switch-like response of genes to the gradient of Shh. Such a mechanism accounting for the conversion of a graded signal into discrete all or none changes in gene expression is essential for the function of a morphogen. Moreover, the principle of cross-repressive interactions observed in the neural tube resembled mechanisms involved in other developing tissues, such as the anterioposterior patterning of the Drosophila embryo (Small and Levine, 1991). Thus, it may represent a general strategy for the regional allocation of cell fate in response to graded inductive signals. Patching a direct link Although the ability of Shh to induce distinct neuronal subtypes in a concentration-dependent manner suggested that Shh acted directly at long range to control gene expression, no direct in vivo observation of a gradient of Shh protein had been made. It was possible, therefore, that Shh exerted its long-range effect by inducing an intermediary signal to relay positional information to the neural tube. To test the range of Shh signalling, I worked with Yu Chen in Gary Struhl's lab, handily located on the floor above the Jessell lab. They had previously shown, with a series of exquisite genetic experiments in Drosophila, that Patched (Ptc) was the receptor for Hh and binding of Hh to Ptc restricted the movement of Hh through tissue (Chen and Struhl, 1996). They went on to construct mutated forms of Ptc that acted as dominant inhibitors of signalling in both Drosophila and vertebrates. Mosaic expression of the vertebrate version of the mutant Ptc construct in the neural tube inhibited Shh signalling in transfected cells and resulted in the cell-autonomous inhibition of the cell types normally found in the ventral neural tube (Briscoe et al, 2001). This indicated that Shh acted directly at long range to control gene expression and cell fate in the neural tube. Moreover, I noticed that the blockade of signalling resulted in more dorsally positioned cells responding as if exposed to a higher concentration of Shh. This indicated that, similar to Hh in Drosophila, a feedback mechanism limited the spread of Shh in the neural tube; consequently, blocking signalling increased the range of Shh. These conclusions were further supported by work from Andrew McMahon's lab, including the recent direct demonstration of a gradient of Shh in the neural tube (Gritli-Linde et al, 2001; Jeong and McMahon, 2005; Chamberlain et al, 2008). Collectively, the studies argued strongly against signal relay models and indicated that Shh functions over a distance in the neural tube. Together with evidence of its concentration-dependent activity, this confirmed that Shh signalling, in the neural tube, meets the strict definition of a morphogen. These studies established graded Shh signalling in the neural tube as an experimentally tractable system for understanding the molecular mechanism of morphogen action. This prompted the question of how cells convey the external concentration of Shh through the signal-transduction pathway to regulate differential gene expression in the nucleus. It is this ‘information processing’ question that I was keen to tackle as I set up my own lab and, despite several interesting and fruitful sidetracks, this is still the main occupation of the lab. In another fortunate coincidence of timing, as I was looking for an independent position, I learnt that NIMR wanted to recruit several new group leaders. The collegiate atmosphere and the support of senior members of the institute immediately impressed me and I jumped at the opportunity when offered a position. However, what was not clear to me until the day I started, was that the temporary space I had been allocated was at the very top of the building underneath the roof, inaccessible by elevator and barely heated. Although I was used to the cold from winters in New York, it was a shock to my first student who arrived in my lab, during a cold spell, straight from her home on the Mediterranean island of Crete. In spite of this, she stayed and within a few months we moved into new lab space on a more salubrious floor of the institute complete with its own thermostat. Since then the environment and my colleagues have been wonderful; the exchange of ideas, the rigorous questioning during internal seminars and the generous sharing of reagents and resources make NIMR a fantastic and stimulating place to work. The Gli-tzy ways of Shh signalling We focused on the question of how graded information from Shh signalling is perceived and transmitted in responding cells. Intracellular Shh signalling depends on two transmembrane proteins: Ptc1, already mentioned, the receptor which binds Hh proteins, and Smoothened (Smo), which is responsible for transducing Hh signals intracellularly (for reviews, see Ingham and McMahon, 2001; Varjosalo and Taipale, 2008). In the absence of Shh, Ptc1 inhibits Smo activity, and binding of Shh to Ptc1 releases this inhibition allowing intracellular signal transduction. The exact mechanism of signal transmission downstream of Smo remains unclear and is the subject of much interest. However, the evidence suggests that the signal concludes with the regulation of a family of zinc-finger containing transcriptional effectors known as Gli proteins (Gli1, 2 and 3). All three Gli genes are expressed in the neural tube and several studies had begun to examine the functions they have in neural tube patterning (Jacob and Briscoe, 2003; Ruiz i Altaba et al, 2003). Michael Matise in Alex Joyner's lab had shown that a targeted deletion of Gli2 in mouse embryos (Matise et al, 1998) led to a failure in the generation of the floor plate and the adjacent domain of V3 neuron progenitors: these are the cell types induced by highest concentrations of Shh. Concomitant with the loss of these cell types, there was a ventral expansion in the production of neighbouring MNs, whereas neuronal classes located dorsal to MNs were unaffected. A compound mutant lacking both Gli1 and Gli2 had more severe defects than Gli2−/− mutants (Park et al, 2000); however, these embryos still produced MNs and interneurons dorsal to MNs. This suggested that Gli2, with partially redundant assistance from Gli1, is required for specifying the cell types that require the highest levels of Shh signalling. The data did, however, leave open the question of the role of Gli3 and whether Gli activity was involved in controlling all responses to Shh. Despina Stamataki, the PhD student from Crete, having acclimatized to the weather, collaborated with Johan Ericson (now back in Stockholm) and his lab to test the involvement of Gli activity and the function of Gli3 in neural patterning. Despina used a truncated version of Gli3 that lacked the transcriptional activation domains but retained its inhibitory function to block all Gli transcriptional activation in the chick neural tube. Similar to the results with the mutant Ptc1 construct that inhibited signalling, the truncated Gli3 caused a ventral-to-dorsal shift in progenitor cell identity and a concomitant failure to generate MNs and ventral interneurons (Persson et al, 2002; Meyer and Roelink, 2003). This confirmed the central importance of Gli activity in the provision of positional information to cells responding to graded Shh signalling. Gli3 had been proposed to function primarily as an inhibitor of Shh signalling in the neural tube. Supporting this idea, in the absence of Gli3, progenitor domains located in the intermediate region of the neural tube expanded dorsally, concomitant with a switch in the identity of the neurons generated in this region. This phenotype was corrected in mice bearing a targeted allele of Gli3, made in Uli Ruther's lab. This allele encodes only a truncated isoform of Gli3 (Böse et al, 2002), equivalent to proteolytically processed Gli3. Moreover, abolishing Gli3 function in Shh−/− embryos partially restored the expression of several ventral progenitor transcription factors that are normally lost in Shh mutant embryos (Litingtung and Chiang, 2000). This supported the idea that only repressor activity of Gli3 is required in the neural tube. Although ventral cell types were generated in the Shh;Gli3 double mutants, the patterning is somewhat disrupted, in particular the strict DV organization characteristic of the normal neural tube is less evident (Litingtung and Chiang, 2000). This suggested two things. First, the induction of most ventral cell types can take place in the absence of Shh signalling, as long as the repressive activity of Gli3 is removed. Second, other extrinsic signals might provide positional information, albeit less accurately, to the ventral neural tube when Shh signalling is removed. Thus, without transcriptional input from Gli proteins, cells lack the positional information provided by Shh signalling, nevertheless, the cross-repressive interactions between progenitor transcription factors remain. Therefore, within individual progenitors, stochastic bias or other external signals might determine gene expression. In this situation, the stochastic biases or the imprecision of other external signals means that neighbouring cells could adopt different positional identities resulting in a neural tube consisting of intermixed cell identities. In this context, it is interesting to note that BMP signallin" @default.
- W2046798922 created "2016-06-24" @default.
- W2046798922 creator A5019391436 @default.
- W2046798922 date "2009-02-05" @default.
- W2046798922 modified "2023-10-17" @default.
- W2046798922 title "Making a grade: Sonic Hedgehog signalling and the control of neural cell fate" @default.
- W2046798922 cites W1481472040 @default.
- W2046798922 cites W1521367633 @default.
- W2046798922 cites W1538129425 @default.
- W2046798922 cites W1743711678 @default.
- W2046798922 cites W1964815717 @default.
- W2046798922 cites W1967671268 @default.
- W2046798922 cites W1969979508 @default.
- W2046798922 cites W1976520395 @default.
- W2046798922 cites W1978833015 @default.
- W2046798922 cites W1982087641 @default.
- W2046798922 cites W1990633759 @default.
- W2046798922 cites W1992865216 @default.
- W2046798922 cites W1993316321 @default.
- W2046798922 cites W2006047257 @default.
- W2046798922 cites W2016350172 @default.
- W2046798922 cites W2017204222 @default.
- W2046798922 cites W2021103771 @default.
- W2046798922 cites W2028497134 @default.
- W2046798922 cites W2029275361 @default.
- W2046798922 cites W2034809706 @default.
- W2046798922 cites W2056123267 @default.
- W2046798922 cites W2059614045 @default.
- W2046798922 cites W2064441783 @default.
- W2046798922 cites W2066729924 @default.
- W2046798922 cites W2075994912 @default.
- W2046798922 cites W2077802746 @default.
- W2046798922 cites W2081235375 @default.
- W2046798922 cites W2082807347 @default.
- W2046798922 cites W2083249373 @default.
- W2046798922 cites W2084024013 @default.
- W2046798922 cites W2086597509 @default.
- W2046798922 cites W2090204791 @default.
- W2046798922 cites W2092195800 @default.
- W2046798922 cites W2096343699 @default.
- W2046798922 cites W2103635980 @default.
- W2046798922 cites W2106436941 @default.
- W2046798922 cites W2107394975 @default.
- W2046798922 cites W2108707301 @default.
- W2046798922 cites W2109976541 @default.
- W2046798922 cites W2110126772 @default.
- W2046798922 cites W2114455979 @default.
- W2046798922 cites W2114702304 @default.
- W2046798922 cites W2117240631 @default.
- W2046798922 cites W2122312331 @default.
- W2046798922 cites W2125266161 @default.
- W2046798922 cites W2136930579 @default.
- W2046798922 cites W2138526982 @default.
- W2046798922 cites W2139168265 @default.
- W2046798922 cites W2142951125 @default.
- W2046798922 cites W2144274759 @default.
- W2046798922 cites W2151665764 @default.
- W2046798922 cites W2153904514 @default.
- W2046798922 cites W2158602749 @default.
- W2046798922 cites W2160889747 @default.
- W2046798922 cites W2161282017 @default.
- W2046798922 cites W2399467729 @default.
- W2046798922 cites W3184018328 @default.
- W2046798922 cites W318497777 @default.
- W2046798922 cites W4230288094 @default.
- W2046798922 cites W4248042899 @default.
- W2046798922 cites W76992116 @default.
- W2046798922 doi "https://doi.org/10.1038/emboj.2009.12" @default.
- W2046798922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2647768" @default.
- W2046798922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19197245" @default.
- W2046798922 hasPublicationYear "2009" @default.
- W2046798922 type Work @default.
- W2046798922 sameAs 2046798922 @default.
- W2046798922 citedByCount "70" @default.
- W2046798922 countsByYear W20467989222012 @default.
- W2046798922 countsByYear W20467989222013 @default.
- W2046798922 countsByYear W20467989222014 @default.
- W2046798922 countsByYear W20467989222015 @default.
- W2046798922 countsByYear W20467989222016 @default.
- W2046798922 countsByYear W20467989222017 @default.
- W2046798922 countsByYear W20467989222018 @default.
- W2046798922 countsByYear W20467989222019 @default.
- W2046798922 countsByYear W20467989222020 @default.
- W2046798922 countsByYear W20467989222021 @default.
- W2046798922 countsByYear W20467989222022 @default.
- W2046798922 countsByYear W20467989222023 @default.
- W2046798922 crossrefType "journal-article" @default.
- W2046798922 hasAuthorship W2046798922A5019391436 @default.
- W2046798922 hasBestOaLocation W20467989222 @default.
- W2046798922 hasConcept C104317684 @default.
- W2046798922 hasConcept C1491633281 @default.
- W2046798922 hasConcept C163952510 @default.
- W2046798922 hasConcept C169760540 @default.
- W2046798922 hasConcept C2776637008 @default.
- W2046798922 hasConcept C2992459734 @default.
- W2046798922 hasConcept C39743133 @default.
- W2046798922 hasConcept C54355233 @default.
- W2046798922 hasConcept C62478195 @default.